Autophagy, p53, and Pancreatic Cancer

Trials to test hydroxychloroquine, an inhibitor of autophagy, for pancreatic cancer are in progress. A recent study suggests that, in some circumstances, hydroxychloroquine may hasten the progression to invasive pancreatic ductal adenocarcinoma.